Meetings: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel

Federal Register: May 4, 2009 (Volume 74, Number 84)

Notices

Page 20487

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr04my09-61

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Disease, Disability, and Injury Prevention and Control Special

Emphasis Panel (SEP): Organ Transplant Infection Detection and

Prevention Program, Funding Opportunity Announcement (FOA) CK09-003,

Initial Review

In accordance with Section 10(a)(2) of the Federal Advisory

Committee Act (Pub. L. 92-463), the Centers for Disease Control and

Prevention (CDC) announces the aforementioned meeting.

Time and Date: 12 p.m.-3 p.m., June 11, 2009 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5

U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ``Organ Transplant Infection

Detection and Prevention Program, FOA CK09-003.''

Contact Person for More Information: Wendy Carr, PhD, CDC, 1600

Clifton Road, NE., Mailstop D60, Atlanta, GA 30333, Telephone: (404) 498-2276.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and

Disease Registry.

Dated: April 24, 2009.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease

Control and Prevention.

FR Doc. E9-10193 Filed 5-1-09; 8:45 am

BILLING CODE 4163-18-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT